The close structural similarity of several of the deoxystreptamine-containing aminoglycoside antibiotics (gentamicins, neomycins, kanamycins, tobramycin) and the recent isolation of enzymatically N-acetylated aminoglycosides have permitted a systematic comparison of the structure-activity relationships in this group of antibiotics. The number and location of amino groups on the hexoses and the site of attachment of the other rings to deoxystreptamine have been shown to exert a profound effect on the ability of these compounds to inhibit or to cause misreading of polypeptide synthesis in vitro. The conclusions allow certain predictions to be made concerning the interaction of these compounds with the bacterial ribosome.
The close structural similarity of several of the deoxystreptamine-containing aminoglycoside antibiotics (gentamicins, neomycins, kanamycins, tobramycin) and the recent isolation of enzymatically N-acetylated aminoglycosides have permitted a systematic comparison of the structure-activity relationships in this group of antibiotics. The number and location of amino groups on the hexoses and the site of attachment of the other rings to deoxystreptamine have been shown to exert a profound effect on the ability of these compounds to inhibit or to cause misreading of polypeptide synthesis in vitro. The conclusions allow certain predictions to be made concerning the interaction of these compounds with the bacterial ribosome.
Most studies on structure-activity relationships among antibiotic analogues have been carried out on whole cells. Although this approach is important in finding new antibiotics, it does not always give exact structure-activity information since many compounds may not enter the cell. Studies of antibiotics at their site of action have been somewhat limited, although cell-free systems which carry out the accurate synthesis of macromolecules are available. One such system is protein synthesis, where a variety of antibiotics have been useful in mechanistic studies.
The aminoglycoside-aminocyclitol antibiotics (streptomycin, spectinomycin, neomycins, paromomycin, kanamycins, gentamicins, tobramycin) inhibit protein synthesis through an interaction with the 30S ribosomal subunit (12) . Structure-activity studies with these antibiotics might provide useful information on the chemistry of the ribosome, as well as suggesting routes for synthetic or semisynthetic production of antibiotics.
Past studies have shown marked differences in activity between different classes of these antibiotics, but recently a number of new deoxystreptamine antibiotics and some enzymatically modified derivatives of gentamicin, kanamycin, and neomycin have become available. A ' (8) of Escherichia coli MRE-600 (prototroph, RNase-). Incorporation was started by the addition of 1 OD,., unit of R17 phage RNA. Incubation was carried out for 40 min at 37 C; then 1.5 ml of 10% trichloroacetic acid was added and the tubes were heated at 90 C for 20 min, cooled, filtered on glass fiber disks, and counted in a liquid scintillation counter.
Misreading of poly U. Reaction mixtures (100 Mliters) were the same as above except 13 , and gentamicin C,2-adenylylate (2) were prepared by using enzymes obtained from resistant bacterial strains as previously described.
RESULTS
The deoxystreptamine-containing aminoglycoside antibiotics include the neomycins and paromomycins ( Fig. 1 3), and tobramycin (Fig. 4) which has been suggested (4, 5) is that the antibiotics can interact with ribosomes at more than one site depending on the drug concentration.
Effects of the aminoglycosides and their derivatives on poly U-directed misreading. The activity of the aminoglycoside antibiotics on polypeptide-synthesizing systems from bacteria can be demonstrated in two ways. On one hand the drugs inhibit "natural" messenger RNA-directed synthesis (see above), and on the other the drugs induce translational errors (misreading) in synthetic polymer-directed synthesis. The latter system can be assayed by measuring the extent of incorporation of the amino acids serine, isoleucine, and tyrosine in the presence of poly U and antibiotic. The significance of this effect on the mode of action of the drugs is not clear, but it does provide a very simple and sensitive assay for biological activity (5). Drug-induced misreading often occurs at concentrations of antibiotic which are too low to inhibit protein synthesis, and it is an accurate probe for structure-activity relationships.
All of the aminoglycosides and their deriva- clear from the data presented in Table 1 that the 1,2 substituted deoxystreptamines are the more potent antibiotics. Since several of the aminoglycosides have close structural similarities, certain conclusions can be drawn about the effects of various amino and hydroxyl moieties on the biological activity of these compounds.
Effects of amino groups in the hexose linked to the 4-position of deoxystreptamine on the biological activity of the aminoglycosides. Kanamycins A, B, and C differ only in the number and location of the amino groups in the hexoses in the 4-position (Fig. 2) . Kanamycin A has a 6'-amino-6'-deoxy-D-glucose ring, kanamycin C has a 2'-amino-2'-deoxy-D-glucose, and kanamycin B has a 2', 6'-diamino-2'6'-dideoxy-D-glucose ring. The extent of inhibition of R17 RNA-directed polypeptide synthesis by these antibiotics is shown in Fig. 5 . As can be seen, kanamycin B is a more potent antibiotic than either kanamycins A or C. The presence of a diamino hexose, therefore, results in a compound that is a better inhibitor of protein synthesis than one containing only one amino group. This same conclusion is obtained by comparing neomycin and paromomycin. The data in Table 1 indicate that neomycin is a more potent antibiotic than paromomycin. The only difference between these compounds is that the former contains a 2', 6'-diamino-2'6'-dideoxy-D-glucose ring, and the latter a 2'-amino-2-deoxy-D-glucose moiety, at the 4-position of deoxystreptamine (Fig. 1) . Kanamycin A is a better inhibitor of protein synthesis than kanamycin C (Fig. 5) . Therefore, when only one amino group is present, an antibiotic that contains a 6-amino substituent is more active than one containing a 2-amino substituent.
One of the ways that the aminoglycosides can be modified is by acetylation of various amino groups by enzymes that are present in bacterial strains resistant to these antibiotics (1). It has been observed that the acetylation of an aminoglycoside does not always eliminate biological activity (1). The only aminoglycoside that is inactivated by enzymatic N-acetylation of the aminohexose ring in the 6-position is kanamycin A; 6'-N-acetylkanamycin A is not an antibiotic (Fig. 5) . However, 6'-N-acetylkanamycin B still retains considerable biological activity. Since 6'-N-acetylkanamycin B very closely resembles kanamycin C in the extent of inhibition of protein synthesis, it seems that acetylation simply neutralizes the contribution of amino groups. As would be expected, 6'-N-acetylneomycin B is very similar to paromomycin in biological activity. It can thus be concluded that at least one amino group is required in the aminohexose at the 4-position for the compound to retain biological activity.
This same pattern of relative activity is observed with the gentamicins and their acetylated derivatives (Fig. 6) . Gentamicin C18, which contains two amino groups in the purpurosamine ring (Fig. 3) , is the most potent antibiotic, followed by 2'-N-acetylgentamicin C18 (which has a free 6'-amino group) and by 6'-N-acetylgentamicin C1l (which has a free 2'-amino group). To summarize: antibiotic activity can be related to the number and location of amino groups in the hexose moiety glycosidically linked to the 4-position of deoxystreptamine as follows (in decreasing order of potency): 2', 6'-diamino > 6'-amino > 2'-amino > no amino
The patterns of misreading activity are also strongly dependent on the number of amino groups. Those antibiotics with a 2,6-diamino sugar (tobramycin, kanamycin B, gentamicins Cla, Cl, or C2, neomycins B or C) show a unique pattern of misreading. There is a progressive increase in the level of misreading over a broad concentration range (0.1 to 15 Ag/ml, about 10-7 to 10' M), followed by a marked inhibition of misreading at higher concentrations (Fig. 7-9 ). The compounds with one amino group (kanamycins A and C, paromomycin, (Fig. 7) .
Streptomycin shows only a very gradual increase in misreading of poly U as the antibiotic concentration is increased from 10-6 to 10-i M (5). Bacterial mutants with altered ribosomes that are resistant to either streptomycin or paromomycin have been obtained, but no ribosomal resistant mutants have been isolated for gentamicins C16, Cl, C2, kanamycin B, or neomycin. Perhaps these latter antibiotics have more than one binding site on the ribosome; the second site may be the one responsible for the inhibition of misreading at high concentrations (5) . Only those antibiotics with a 2,6-aminohexose show biphasic inhibition and misreading curves. Two mutations might therefore be needed to obtain a strain containing ribosomes resistant to these antibiotics. It may be possible to select for a strain that is resistant to neomycin by starting with one that is resistant to paromomycin. Similarly, kanamycin B-or gentamicin Cia-resistant strains might be obtained by selecting first for ribosomal resistance to kanamycins A or C or to gentamicin A (or 2'-N-acetylgentamicin C16), respectively. It is not possible to state what role the amino groups play in the interaction of the antibiotic with the ribosome; they could be involved in hydrogen bonding or ionic interactions.
Effect of hydroxylation of the hexose glycosidically linked to the 4-position of 2- deoxystreptamine. Kanamycin B and tobramycin are identical in structure except that the latter lacks a 3-hydroxyl moiety (compare Fig. 2 and 4) . Both are equally effective in inhibiting protein synthesis (Table 1) . Therefore, the presence or absence of a hydroxyl group at the 3'-position of this hexose does not have a great effect on the activity of these antibiotics. Gentamicin C16 contains purpurosamine (a 3', 4'-dideoxy sugar) (Fig. 3) and is as good an antibiotic as kanamycin B. These three antibiotics differ only slightly in misreading activity ( Fig. 7 and 8) , they all produce greater misreading with increasing concentrations up to approximately 10 gg/ml, and a further increase in concentration is then strongly inhibitory. It is apparent that the degree of hydroxylation of the sugar in the 4-position of deoxystreptamine has no effect on the activity of these antibiotics.
That the presence or absence of hydroxyl groups does not have a marked effect on the biological activity of these aminoglycosides can also be seen by comparing the activities of neamine, tobramine (3-deoxy), and gentamine Cla (3',4'-dideoxy) (see Table 1 ). These three compounds, which consist of only one diaminohexose linked to deoxystreptamine, have essentially identical biological activity in vitro.
The aminoglycosides lacking the 3-hydroxyl group are not substrates for neomycinkanamycin phosphotransferase, an enzyme found in bacteria resistant to neomycin and kanamycin, since this enzyme phosphorylates that hydroxyl group in the aminoglycosides.
Since the 3'-deoxy compounds are potent antibiotics, they are currently being used to treat infections involving bacteria that are resistant to kanamycin and neomycin. Phosphorylation of the 3-hydroxyl leads to complete inactivation since the phosphorylated antibiotic can no longer bind to the ribosome (13). The studies described here suggest that inactivation occurs because the hydroxyl group is replaced by a bulky charged group and not as a result of blocking a functionally important hydroxyl group. Effect of other substituents on the deoxystreptamine ring on the biological activity of the aminoglycosides. Kanamycin B, tobramycin, and gentamicin C16 also differ in the nature of the substituent at the 6-position of deoxystreptamine. The former two compounds have a kanosamine substituent ( Fig. 2 and 4) , and the latter has garosamine. Since there is very little difference in the in vitro biological activity of tobramycin, kanamycin B, and gentamicin C16, and between gentamicin A and kanamycin C, we conclude that although kanosamine and garosamine have substantial roles in determining antibiotic potency (i.e., compare tobramycin with tobramine and gentamicin C16 with gentamine C16), they are very similar in this respect.
These substituents are important, however, in the recognition of these compounds by the various aminoglycoside inactivating enzymes. For example, the enzyme which acetylates the 3-amino group in the deoxystreptamine ring of gentamicin C16 (Fig. 3) does not recognize this same group in kanamycin B or tobramycin. This specificity is presumably determined by differences in the substituents on the deoxystreptamine ring (3).
The neomycins are structurally different from the kanamycins and gentamicins in that substituents are on adjacent hydroxyls (4, 5) of deoxystreptamine ( Fig. 1) 4, 1973 on June 21, 2017 by guest http://aac.asm.org/ Downloaded from neomycin B, neomycin C, butirosin, ribostamycin, neamine, and methyl neobiosaminide B. Therefore, the presence of all four rings yields maximal activity, followed by three rings, and then two. Neamine is a good antibiotic, and methyl neobiosaminide B is not; the latter compound inhibits phage RNA-directed protein synthesis by only 10% at 50 .ug/ml. The lack of activity of methyl neobiosaminide B is possibly due to the fact that the C6 substituent is inverted (dihydrosisomicin is inactive) rather than to the replacement of deoxystreptamine by ribose. In this regard it would be interesting to examine the antibacterial activity of methyl neobiosaminide C.
Role of 2-deoxystreptamine in determining the biological activity of the aminoglycosides. It has been proposed that the deoxystreptamine ring is the primary determinant of the biological activity of the aminoglycoside antibiotics (7, 11) . However, it has been shown that deoxystreptamine can be replaced by streptamine (4), and it is apparent from our results that the sugar substituents on the deoxystreptamine ring play the most important role. We have confirmed this supposition by studies with synthetic compounds provided by R. Lemieux.
These compounds contain a 2-deoxystreptamine ring substituted with various sugars and amino sugars. 4, 6-Di-0-(a-D-glucopyranosyl)-deoxystreptamine, which consists of two Dglucose moieties glycosidically linked to 2-deoxystreptamine, is completely inactive in inhibiting protein synthesis (Table 1 ). 4, 6-Di-O-(6-amino -6 -deoxy -a -D -,glucopyranosyl) -deoxystreptamine is only weakly active. Therefore, the presence of a deoxystreptamine moiety is not enough to guarantee antibacterial activity; the deoxystreptamine has to be linked to the appropriate amino sugars. Thus the location of the amino group in the 3-amino-D-glucose moiety (kanosamine) of kanamycin A is important for biological activity. When that sugar is changed to 6-amino-6-deoxy-D-glucose, the compound loses almost all biological activity. 2-Deoxystreptamine has two amino groups. When one of them is enzymatically acetylated by an enzyme found in a gentamicin-resistant strain of Pseudomonas aeruginosa (3) to yield 3-N-acetylgentamicin Cia, the compound is no longer an antibiotic ( Fig. 6 and 8) . In butirosin, the 1-amino group of deoxystreptamine is substituted with 4-amino-2-hydroxybutyric acid, and this does not substantially reduce biological activity in our in vitro assays. This suggests that the 1-amino group of 2-deoxystreptamine may be unimportant for biological activity; however, studies of other compounds with substituents at this position will be necessary to establish this. Similar substitution of kanamycin results in an antibiotic (BBK-8) which differs little in activity from kanamycin. The importance of this substitution is that it increases antiPseudomonas activity and makes the compound inert to various forms of inactivation (9) . General conclusions. We have shown that the number and location of amino groups in the sugars attached to deoxystreptamine profoundly affect the biological activity of the aminoglycoside antibiotics. The presence of at least one amino group in these sugars is needed for biological activity. The addition of extra substituents to the deoxystreptamineaminosugar combination (even a ribose moiety as in ribostamycin) can further increase the biological activity of these compounds.
As new aminoglycosides and additional enzymatically modified derivatives become available, it may be possible to derive additional conclusions as to the biological activity of these antibiotics. The structural requirements for substrate activity for the nine aminoglycoside inactivating enzymes that have so far been discovered have been reviewed (R. Benveniste and J. Davies, Annu. Rev. Biochem., in press). Fortunately, the requirements for activity as an enzyme substrate are somewhat different from those for antibiotic activity, or the design of new aminoglycosides that could inhibit resistant bacterial strains would not be possible.
The ribosome is a very complicated macromolecule, and genetic studies with ribosomes from antibiotic-resistant strains of bacteria have proved useful in characterizing certain of the protein components (6) . Among the aminoglycoside-aminocyclitol antibiotics there are distinct binding sites for the streptomycin-type compounds, spectinomycin, and kasugamycin, which have been established by studies of resistant mutants. In the case of the antibiotic groups typified by kanamycin and neomycin, it is not known if these two groups share the same binding site or have separate sites. The binding of neomycin to ribosomes affects the binding of streptomycin (13) ; kanamycin has no effect. The effects of both neomycin and kanamycin B on protein synthesis appear to be the result of multiple binding. The binding of aminoglycoside-aminocyclitols to the ribosome would seem to be the role predominantly of amino groups in these antibiotics.
We have completely ignored one important aspect of the aminoglycoside antibiotics-their toxicity. There is a need for a simple and direct assay which would relate structural require-
